Cell MedX Corp. Quarterly Return On Equity in % from Q1 2019 to Q2 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cell MedX Corp. quarterly/annual Return On Equity history and growth rate from Q1 2019 to Q2 2022.
  • Cell MedX Corp. Return On Equity for the quarter ending May 31, 2022 was 39.2 %, a 28.5% decline year-over-year.
  • Cell MedX Corp. annual Return On Equity for 2021 was 42 %, a 95.9% decline from 2020.
  • Cell MedX Corp. annual Return On Equity for 2020 was 1.03K %, a 1348% increase from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2022 39.2 -15.7 -28.5% Mar 1, 2022 May 31, 2022
Q1 2022 52.5 +6.73 +14.7% Dec 1, 2021 Feb 28, 2022
Q4 2021 55.6 -5.07 -8.35% Sep 1, 2021 Nov 30, 2021
Q3 2021 56.6 -82.9 -59.4% Jun 1, 2021 Aug 31, 2021
Q2 2021 54.9 -1.18K -95.5% Mar 1, 2021 May 31, 2021
Q1 2021 45.7 -649 -93.4% Dec 1, 2020 Feb 28, 2021
Q4 2020 60.7 -496 -89.1% Sep 1, 2020 Nov 30, 2020
Q3 2020 140 +40.9 +41.5% Jun 1, 2020 Aug 31, 2020
Q2 2020 1.23K +1.17K +1996% Mar 1, 2020 May 31, 2020
Q1 2020 695 +622 +851% Dec 1, 2019 Feb 29, 2020
Q4 2019 557 Sep 1, 2019 Nov 30, 2019
Q3 2019 98.6 Jun 1, 2019 Aug 31, 2019
Q2 2019 58.8 Mar 1, 2019 May 31, 2019
Q1 2019 73.1 Dec 1, 2018 Feb 28, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.